Rachid Izzar - 06 Feb 2026 Form 4 Insider Report for BIOGEN INC. (BIIB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Feb 2026, 17:00:19 UTC
Prior SEC filing
16 Jul 2025
Next SEC filing
17 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar

Key filing fact

Rachid Izzar filed Form 4 for BIOGEN INC. (BIIB) on 10 Feb 2026.

Key facts

  • This page summarizes Rachid Izzar's Form 4 filing for BIOGEN INC. (BIIB).
  • 9 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 10 Feb 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 16 Jul 2025.
  • Current net transaction value: -$410,005.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001875506 Primary reporting owner

Izzar Rachid

Relationship
Head of Global Product Strat.
Address
225 BINNEY STREET, CAMBRIDGE
Signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Signature date
10 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BIIB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,044
Change %
+33%
Price
$0.000000
Shares after
8,204
Date
06 Feb 2026
Ownership
Direct
Footnotes
F1
BIIB transaction

Common Stock

Tax liability

Transaction value
$161,950
Shares
-805
Change %
-9.8%
Price
$201.18
Shares after
7,399
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+1,802
Change %
+24%
Price
$0.000000
Shares after
9,201
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Tax liability

Transaction value
$92,140
Shares
-458
Change %
-5%
Price
$201.18
Shares after
8,743
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+3,043
Change %
+35%
Price
$0.000000
Shares after
11,786
Date
06 Feb 2026
Ownership
Direct
BIIB transaction

Common Stock

Tax liability

Transaction value
$155,914
Shares
-775
Change %
-6.6%
Price
$201.18
Shares after
11,011
Date
06 Feb 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BIIB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-2,044
Change %
-100%
Price
$0.000000
Shares after
0
Date
06 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,044
Exercise price
$0.000000
Footnotes
F2
BIIB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,802
Change %
-50%
Price
$0.000000
Shares after
1,802
Date
06 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,802
Exercise price
$0.000000
Footnotes
F3
BIIB transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-3,043
Change %
-33%
Price
$0.000000
Shares after
6,087
Date
06 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,043
Exercise price
$0.000000
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.

Footnote F2

The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/08/2023.

Footnote F3

The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.

Footnote F4

The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .